The amyloid β (Aβ) fibril is a hallmark of Alzheimer’s disease (AD) and has therefore served as an important target for early diagnosis of AD. The Pittsburgh Compound-B (PiB) is one of the most famous positron emission tomography (PET) tracers commonly used for in vivo detection of Aβ fibrils. Many theoretical studies have predicted the existence of various core binding sites with different microenvironments for probes binding to the Aβ fibril. However, little attention has been devoted to how the probes actually penetrate into the different core binding sites. In this study, an integrated molecular modeling scheme is used to study the penetration of PiB into the core binding sites of the Aβ1–42 fibril structure recently obtained by cryogen...
Background/Purpose: We have successfully visualized amyloid- (A) deposition in a mouse model of Alzh...
18F-FIBT, 2-(p-Methylaminophenyl)-7-(2-[18F]fluoroethoxy)imidazo-[2,1-b]benzothiazole, is a new sele...
Introduction: Amyloid imaging has been integrated into diagnostic criteria for Alzheimer's disease (...
The neuropathology of Alzheimer's disease (AD) includes amyloid plaque formation by the amyloid β-pr...
Imaging fibrillar amyloid-β deposition in the human brain in vivo by positron emission tomography ha...
The accumulation of amyloid fibrils is characteristic of neurodegenerative diseases such as Alzheime...
PurposeExtensive deposition of senile plaques and neurofibrillary tangles in the brain is a patholog...
Alzheimer's disease and primary tauopathies are characterized by the presence of tau pathology in br...
Tauopathies are a subclass of neurodegenerative diseases characterized by an accumulation of microtu...
Amyloid imaging by positron emission tomography (PET) is an important method for diagnosing neurodeg...
Alzheimer’s disease (AD) is the most common type of dementia. A series of pathophyslogical changes s...
AbstractPittsburgh compound B (PIB) is a neutral derivative of the fluorescent dye Thioflavin T (ThT...
This single case study examines selective Pittsburgh compound-B (PiB) binding to an intracerebral li...
Alzheimer’s disease is a challenge of the utmost importance for contemporary society. An early diagn...
This report describes the first human study of a novel amyloid-imaging positron emission tomography ...
Background/Purpose: We have successfully visualized amyloid- (A) deposition in a mouse model of Alzh...
18F-FIBT, 2-(p-Methylaminophenyl)-7-(2-[18F]fluoroethoxy)imidazo-[2,1-b]benzothiazole, is a new sele...
Introduction: Amyloid imaging has been integrated into diagnostic criteria for Alzheimer's disease (...
The neuropathology of Alzheimer's disease (AD) includes amyloid plaque formation by the amyloid β-pr...
Imaging fibrillar amyloid-β deposition in the human brain in vivo by positron emission tomography ha...
The accumulation of amyloid fibrils is characteristic of neurodegenerative diseases such as Alzheime...
PurposeExtensive deposition of senile plaques and neurofibrillary tangles in the brain is a patholog...
Alzheimer's disease and primary tauopathies are characterized by the presence of tau pathology in br...
Tauopathies are a subclass of neurodegenerative diseases characterized by an accumulation of microtu...
Amyloid imaging by positron emission tomography (PET) is an important method for diagnosing neurodeg...
Alzheimer’s disease (AD) is the most common type of dementia. A series of pathophyslogical changes s...
AbstractPittsburgh compound B (PIB) is a neutral derivative of the fluorescent dye Thioflavin T (ThT...
This single case study examines selective Pittsburgh compound-B (PiB) binding to an intracerebral li...
Alzheimer’s disease is a challenge of the utmost importance for contemporary society. An early diagn...
This report describes the first human study of a novel amyloid-imaging positron emission tomography ...
Background/Purpose: We have successfully visualized amyloid- (A) deposition in a mouse model of Alzh...
18F-FIBT, 2-(p-Methylaminophenyl)-7-(2-[18F]fluoroethoxy)imidazo-[2,1-b]benzothiazole, is a new sele...
Introduction: Amyloid imaging has been integrated into diagnostic criteria for Alzheimer's disease (...